Population-wide generalizability of genome-wide discovered associations.

@article{Ioannidis2009PopulationwideGO,
  title={Population-wide generalizability of genome-wide discovered associations.},
  author={John P. A. Ioannidis},
  journal={Journal of the National Cancer Institute},
  year={2009},
  volume={101 19},
  pages={
          1297-9
        }
}
  • J. Ioannidis
  • Published 7 October 2009
  • Biology
  • Journal of the National Cancer Institute
JNCI | Editorials 1297 Genome-wide association studies (GWAS) have started revealing hundreds of associations between genetic variants and phenotypes ( 1 , 2 ). Most associations have robust statistical support in the populations where they have been examined. However, almost all GWAS published to date were performed in populations of European ancestry, and the replication efforts in the original publications also focused primarily on similar populations. Are these discovered associations… 

Figures from this paper

Consistency of genome-wide associations across major ancestral groups
TLDR
The modest correlations, differing risk estimates, and considerable between-association heterogeneity suggest that differential ancestral effects can be anticipated and genomic risk markers may need separate further evaluation in different ancestry groups.
High Trans-ethnic Replicability of GWAS Results Implies Common Causal Variants
TLDR
A comprehensive survey of GWAS replicability across 28 diseases indicates that most GWAS results are due to common variants, and the sharing of disease alleles and the high correlation in their effect sizes suggest that most of the underlying causal variants are shared between Europeans and East Asians.
Replication of genome-wide discovered breast cancer risk loci in the Cypriot population
TLDR
Moderate concordance is shown for breast cancer GWAS-discovered alleles and their effect sizes in the Cypriot population, which is better than expected.
Genome-wide significant associations for variants with minor allele frequency of 5% or less--an overview: A HuGE review.
TLDR
Although the number of uncommon variants with genome-wide significance is still limited, these data suggest a possible confluence of rare/uncommon and common genetic variation on the same genetic loci.
Systematic identification of interaction effects between genome- and environment-wide associations in type 2 diabetes mellitus
TLDR
It is hypothesized that impaired function driven by rs13266634 increases T2D risk when combined with serum levels of nutrients, and unbiased consideration of environmental and genetic factors may help identify larger and more relevant effect sizes for disease associations.
Caution in generalizing known genetic risk markers for breast cancer across all ethnic/racial populations
TLDR
The results emphasize the need for large-scale association studies of multiple racial/ethnic groups for discovery and characterization of risk alleles relevant to all populations in the United States.
Genetic architecture of cancer and other complex diseases: lessons learned and future directions.
TLDR
Current knowledge on the genetic architecture of four cancers is reviewed, suggesting that a simple dichotomy between rare and common allelic architectures may be too simplistic and that future research is needed to characterize a fuller spectrum of allele frequency, effect size and effect size.
Racial/Ethnic Variation in the Association of Lipid-Related Genetic Variants With Blood Lipids in the US Adult Population
TLDR
The combined association of SNPs, based on a GRS, was strongly associated with increased blood lipid measures in all major race/ethnic groups in the United States, which may help in identifying subgroups with a high risk for an unfavorable lipid profile.
Genetic Cardiovascular Risk Prediction: Will We Get There?
TLDR
After years of inconsistent results and failure to replicate putative candidate gene associations, high-throughput technologies and novel statistical tools have led to a virtual explosion of novel genetic markers associated with complex human diseases.
...
1
2
3
...

References

SHOWING 1-10 OF 22 REFERENCES
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
TLDR
An online catalog of SNP-trait associations from published genome-wide association studies for use in investigating genomic characteristics of trait/disease-associated SNPs (TASs) is developed, well-suited to guide future investigations of the role of common variants in complex disease etiology.
Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium
TLDR
This study provides strong confirmation of these susceptibility loci in multiple populations and shows that they make an important contribution to prostate cancer risk prediction.
Genome-Wide Association Studies, Field Synopses, and the Development of the Knowledge Base on Genetic Variation and Human Diseases
TLDR
Current experience and challenges on integrating evidence from genome-wide association studies and candidate gene studies, and a vision of collaboration that builds reliable cumulative evidence for genetic associations with common complex diseases and a transparent, distributed, authoritative knowledge base on genetic variation and human health are summarized.
A second generation human haplotype map of over 3.1 million SNPs
TLDR
The Phase II HapMap is described, which characterizes over 3.1 million human single nucleotide polymorphisms genotyped in 270 individuals from four geographically diverse populations and includes 25–35% of common SNP variation in the populations surveyed, and increased differentiation at non-synonymous, compared to synonymous, SNPs is demonstrated.
Replication of prostate cancer risk loci in a Japanese case-control association study.
TLDR
The results highlight the critical importance of considering ancestry in understanding how risk alleles influence disease and suggest that risk estimates and variants differ across populations.
Multiple newly identified loci associated with prostate cancer susceptibility
TLDR
A genome-wide association study using blood DNA samples from 1,854 individuals with clinically detected prostate cancer diagnosed at ≤60 years or with a family history of disease, and 1,894 population-screened controls with a low prostate-specific antigen (PSA) concentration (<0.5 ng/ml) identified seven loci associated with prostate cancer on chromosomes 3, 6, 7, 10, 11, 19 and X.
Personalized Genetic Prediction: Too Limited, Too Expensive, or Too Soon?
TLDR
The predictive power to individualize risk remains relatively weak and improvement in prediction of future disease by adding genotypic information to traditional risk factors is subtle, if any, for CVD, prostate cancer, and type 2 diabetes.
'Racial' differences in genetic effects for complex diseases
TLDR
This work addressed the question of whether ancestry influences the impact of each gene variant on the disease risk by examining the genetic effects for 43 validated gene-disease associations across 697 study populations of various descents.
Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.
  • M. Gail
  • Biology
    Journal of the National Cancer Institute
  • 2008
TLDR
These seven common SNPs identified have the potential to improve the discriminatory accuracy of BCRAT modestly, but experience to date and quantitative arguments indicate that a huge increase in the numbers of case patients with breast cancer and control subjects would be required in genome-wide association studies to find enough SNPs to achieve high discriminatory accuracy.
Validating, augmenting and refining genome-wide association signals
TLDR
The steps required to validate, augment and refine such signals to identify underlying causal variants for well-defined phenotypes are addressed, including large-scale exact replication across both similar and diverse populations.
...
1
2
3
...